Cargando…

Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles

NKp30 (Natural Cytotoxicity Receptor 1, NCR1) is a powerful cytotoxicity receptor expressed on natural killer (NK) cells which is involved in tumor cell killing and the regulation of antitumor immune responses. Ligands for NKp30, including BAG6 and B7-H6, are upregulated in virus-infected and tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ponath, Viviane, Hoffmann, Nathalie, Bergmann, Leonie, Mäder, Christina, Alashkar Alhamwe, Bilal, Preußer, Christian, Pogge von Strandmann, Elke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926927/ https://www.ncbi.nlm.nih.gov/pubmed/33671836 http://dx.doi.org/10.3390/ijms22042189

Ejemplares similares

Beyond the Extracellular Vesicles: Technical Hurdles, Achieved Goals and Current Challenges When Working on Adipose Cells
por: Gómez-Serrano, María, et al.
Publicado: (2021)

Epigenetic Regulation of Airway Epithelium Immune Functions in Asthma
por: Alashkar Alhamwe, Bilal, et al.
Publicado: (2020)

The Oncoprotein SKI Acts as A Suppressor of NK Cell-Mediated Immunosurveillance in PDAC
por: Ponath, Viviane, et al.
Publicado: (2020)

Side-Directed Release of Differential Extracellular Vesicle-associated microRNA Profiles from Bronchial Epithelial Cells of Healthy and Asthmatic Subjects
por: Schindler, Viktoria E. M., et al.
Publicado: (2022)

The Immune Microenvironment in Pancreatic Cancer
por: Huber, Magdalena, et al.
Publicado: (2020)

KLF4-mediated upregulation of the NKG2D ligand MICA in acute myeloid leukemia: a novel therapeutic target identified by enChIP
por: Alkhayer, Reem, et al.
Publicado: (2023)

Influenza A Virus Hemagglutinin and Other Pathogen Glycoprotein Interactions with NK Cell Natural Cytotoxicity Receptors NKp46, NKp44, and NKp30
por: Luczo, Jasmina M., et al.
Publicado: (2021)

Role of Exosomes Released by Dendritic Cells and/or by Tumor Targets: Regulation of NK Cell Plasticity
por: Reiners, Katrin S., et al.
Publicado: (2014)

NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2017)

Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
por: Pavlakis, Evangelos, et al.
Publicado: (2023)

Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2019)

Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions
por: Garcia-Iglesias, Trinidad, et al.
Publicado: (2009)

Molecular Determinants for RNA Release into Extracellular Vesicles
por: Mosbach, Marie-Luise, et al.
Publicado: (2021)

Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
por: Han, Bin, et al.
Publicado: (2018)

Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53
por: Schuldner, Maximiliane, et al.
Publicado: (2019)

DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies
por: Shatnyeva, Olga M., et al.
Publicado: (2015)

NKp46 Clusters at the Immune Synapse and Regulates NK Cell Polarization
por: Hadad, Uzi, et al.
Publicado: (2015)

Activatory Receptor NKp30 Predicts NK Cell Activation During Controlled Human Malaria Infection
por: Walk, Jona, et al.
Publicado: (2019)

Expression Analysis of the Ligands for the Natural Killer Cell Receptors NKp30 and NKp44
por: Byrd, Andreina, et al.
Publicado: (2007)

Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
por: Ferlazzo, Guido, et al.
Publicado: (2002)

HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity
por: Peipp, Matthias, et al.
Publicado: (2015)

Late domain dependent E-cadherin recruitment into extracellular vesicles
por: Bänfer, Sebastian, et al.
Publicado: (2022)

NKp46 defines ovine cells that have characteristics corresponding to NK cells
por: Connelley, Timothy, et al.
Publicado: (2011)

NK Cell Receptor NKp46 Regulates Graft-versus-Host Disease
por: Ghadially, Hormas, et al.
Publicado: (2014)

Modulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin
por: Jarahian, Mostafa, et al.
Publicado: (2011)

The Role of Extracellular HSP70 in the Function of Tumor-Associated Immune Cells
por: Linder, Manuel, et al.
Publicado: (2021)

Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1
por: Walwyn-Brown, Katherine, et al.
Publicado: (2018)

A NOVEL B7H3/NKP30 BISPECIFIC NK CELL ENGAGER FOR CANCER IMMUNOTHERAPY
por: Jiang, Xiaoling, et al.
Publicado: (2023)

Phosphoproteomics identify arachidonic-acid-regulated signal transduction pathways modulating macrophage functions with implications for ovarian cancer
por: Dietze, Raimund, et al.
Publicado: (2021)

NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint
por: Shemesh, Avishai, et al.
Publicado: (2016)

Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset
por: Kloess, Stephan, et al.
Publicado: (2017)

Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression
por: Glasner, Ariella, et al.
Publicado: (2017)

Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma
por: Iraqi, Muhammed, et al.
Publicado: (2022)

Viral antigen mediated NKp46 activation of NK cells results in tumor rejection via NK-DC crosstalk
por: Chinnery, Fay, et al.
Publicado: (2012)

Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset
por: Kloess, Stephan, et al.
Publicado: (2018)

Perinatal and Early-Life Nutrition, Epigenetics, and Allergy
por: Acevedo, Nathalie, et al.
Publicado: (2021)

Cancer-derived extracellular vesicles: friend and foe of tumour immunosurveillance
por: Dörsam, Bastian, et al.
Publicado: (2018)

Antigen Loss Variants: Catching Hold of Escaping Foes
por: Vyas, Maulik, et al.
Publicado: (2017)

Rescue of Impaired NK Cell Activity in Hodgkin Lymphoma With Bispecific Antibodies In Vitro and in Patients
por: Reiners, Katrin S., et al.
Publicado: (2013)

NKp30(+) NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B
por: Shen, Xiaokun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_na5o4gfc5r40m4daoupink289g